Redemplo’s approval in familial chylomicronemia syndrome places the drug in competition with Ionis’ Tryngolza.
Alkermes will likely proceed with its planned acquisition of Avadel, which experienced an unexpected hitch following Lundbeck ...
The US FDA has granted approval for AbbVie’s Epkinly to treat adult patients with relapsed or refractory (R/R) follicular ...
The US Patent and Trademark Office (USPTO) has granted a patent to Genprex for the use of its Reqorsa gene therapy ...
Experts from Sharp offer insights into sustainable practices in pharma packaging, highlighting advancements achieved and ...
Insmed has received approval from the EC for Brinsupri to treat NCFB in patients aged 12 and above with two or more ...
Eleva’s CEO says CHO cell line alternatives could become common in therapeutic protein manufacturing, as large molecule drugs become complex and harder to produce at scale.
At two upcoming events, experts will offer practical solutions to key challenges for oncology and rare disease clinical ...
Italvacuum, a leading manufacturer of vacuum pumps and industrial drying systems for the pharmaceutical and fine chemical industries, announced its participation at CPHI | PMEC India 2025, taking ...
The fund will participate in follow-on and initial rounds, focusing on biotech and medtech ventures across core markets.
A CHMP panel has recommended the high-dose version’s approval, countering an FDA rejection for the drug in recent months.
Johnson & Johnson has signed a definitive agreement for the acquisition of Halda Therapeutics (Halda) in a deal valued at ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results